(LEAD) Celltrion's COVID-19 antibody treatment wins emergency approval in Brazil
(ATTN: CLARIFIES info in 2nd para)
By Kim Han-joo
SEOUL, Aug. 12 (Yonhap) -- South Korean pharmaceutical giant Celltrion Inc. said Thursday its COVID-19 antibody treatment has won an emergency approval from Brazilian authorities.
The Agencia Nacional de Vigilancia Sanitaria granted the approval for an emergency application of Rekirona in adult patients suffering a mild form of COVID-19 that may develop into a more severe phase.
The approval was based on recent top-line results from a global phase three clinical study of Rekirona, a pivotal part of the study to obtain more comprehensive safety and efficacy results.
Celltrion is conducting the phase three clinical study of Rekirona in 13 countries on 1,315 critically ill COVID-19 patients.
Rekirona is a monoclonal antibody with activity against COVID-19. A monoclonal antibody is a type of protein that has been designed to attach to a specific structure.
In February, Rekirona won the South Korean drug safety agency's conditional approval, becoming the first locally made treatment for COVID-19.
The drug won its first overseas approval for an emergency application from Indonesia.
Celltrion said Rekirona reduces the risk of progressing to severe COVID-19, compared with patients administered with a placebo. The company said the antibody treatment also reduced the recovery time.
The company plans to submit an application for the formal authorization to the U.S. Food and Drug Administration (FDA) and to the European Medicines Agency (EMA) upon the release of the interim outcome its phase three clinical trial.
khj@yna.co.kr
(END)
-
(Yonhap Interview) Fintech startup AIM aims to bring professional wealth services to ordinary investors
-
N.K. leader declares victory in fight against COVID-19: state media
-
N. Korea appears to release border dam water without prior notice: official
-
7 dead, 6 missing in heaviest rainfall in 80 years
-
(2nd LD) 7 dead, 6 missing in heaviest rainfall in 80 years
-
(Yonhap Interview) Fintech startup AIM aims to bring professional wealth services to ordinary investors
-
7 dead, 6 missing in heaviest rainfall in 80 years
-
(5th LD) 8 dead, 7 missing in record rainfall in Seoul, surrounding areas
-
N. Korea appears to release border dam water without prior notice: official
-
(LEAD) 7 dead, 6 missing in heaviest rainfall in 80 years
-
(LEAD) N. Korea hits out at U.N. chief over remarks on denuclearization
-
(LEAD) Heavy rain-caused deaths stand at 14; number of missing rises to 6
-
(LEAD) New COVID-19 cases down for 4th day; critical cases at over 3-month high
-
Yoon renews pledge to honor people who sacrificed themselves for nation
-
(News Focus) Yoon to mark first 100 days in office amid unusually low approval ratings